Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis

被引:364
作者
Janco, Jo Marie Tran [1 ]
Lamichhane, Purushottam [2 ,3 ]
Karyampudi, Lavakumar [3 ]
Knutson, Keith L. [2 ,3 ]
机构
[1] Mayo Clin, Div Gynecol Surg, Rochester, MN 55906 USA
[2] Mayo Clin, Dept Immunol, Rochester, MN 55906 USA
[3] Vaccine & Gene Therapy Inst, Canc Vaccines & Immune Therapies Program, Port St Lucie, FL 34987 USA
基金
美国国家卫生研究院;
关键词
REGULATORY T-CELLS; HUMAN COLORECTAL-CANCER; NATURAL-KILLER-CELLS; OVARIAN-CANCER; ANTITUMOR IMMUNITY; SUPPRESSOR-CELLS; IN-VIVO; ANTI-PD-1; ANTIBODY; GASTRIC-CANCER; MYELOID CELLS;
D O I
10.4049/jimmunol.1403134
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) play a pivotal role in the tumor microenvironment, which is known to affect disease progression in many human malignancies. Infiltration by mature, active DCs into the tumors confers an increase in immune activation and recruitment of disease-fighting immune effector cells and pathways. DCs are the preferential target of infiltrating T cells. However, tumor cells have means of suppressing DC function or of altering the tumor microenvironment in such a way that immune-suppressive DCs are recruited. Advances in understanding these changes have led to promising developments in cancer-therapeutic strategies targeting tumor-infiltrating DCs to subdue their immunosuppressive functions and enhance their immunestimulatory capacity.
引用
收藏
页码:2985 / 2991
页数:7
相关论文
共 78 条
[1]   Tim-3: An Emerging Target in the Cancer Immunotherapy Landscape [J].
Anderson, Ana C. .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (05) :393-398
[2]   Tim-3, a negative regulator of anti-tumor immunity [J].
Anderson, Ana Carrizosa .
CURRENT OPINION IN IMMUNOLOGY, 2012, 24 (02) :213-216
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]   The who, how and where of antigen presentation to B cells [J].
Batista, Facundo D. ;
Harwood, Naomi E. .
NATURE REVIEWS IMMUNOLOGY, 2009, 9 (01) :15-27
[5]   CD8+ Tumor-Infiltrating T Cells Are Trapped in the Tumor-Dendritic Cell Network [J].
Boissonnas, Alexandre ;
Licata, Fabrice ;
Poupel, Lucie ;
Jacquelin, Sebastien ;
Fetler, Luc ;
Krumeich, Sophie ;
Thery, Clotilde ;
Amigorena, Sebastian ;
Combadiere, Christophe .
NEOPLASIA, 2013, 15 (01) :85-+
[6]  
Botti C, 1998, INT J BIOL MARKER, V13, P51
[7]   High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial [J].
Canioni, Danielle ;
Salles, Gilles ;
Mounier, Nicolas ;
Brousse, Nicole ;
Keuppens, Marie ;
Morchhauser, Frank ;
Lamy, Thierry ;
Sonet, Anne ;
Rousselet, Marie-Christine ;
Foussard, Charles ;
Xerri, Luc .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) :440-446
[8]   Inflammation-related factors predicting prognosis of gastric cancer [J].
Chang, Wen-Jun ;
Du, Yan ;
Zhao, Xin ;
Ma, Li-Ye ;
Cao, Guang-Wen .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (16) :4586-4596
[9]   The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation [J].
Chen, Wei ;
Liang, Xueqing ;
Peterson, Amanda J. ;
Munn, David H. ;
Blazar, Bruce R. .
JOURNAL OF IMMUNOLOGY, 2008, 181 (08) :5396-5404
[10]   Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein [J].
Cheng, Pingyan ;
Corzo, Cesar A. ;
Luetteke, Noreen ;
Yu, Bin ;
Nagaraj, Srinivas ;
Bui, Marylin M. ;
Ortiz, Myrna ;
Nacken, Wolfgang ;
Sorg, Clemens ;
Vogl, Thomas ;
Roth, Johannes ;
Gabrilovich, Dmitry I. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (10) :2235-2249